LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 83

Search options

  1. Article ; Online: FGFR regulator Memo1 is dispensable for FGF23 expression by osteoblasts during folic acid-driven kidney injury.

    Bartos, Katalin / Moor, Matthias B

    Physiological reports

    2023  Volume 11, Issue 6, Page(s) e15650

    Abstract: Loss of the mediator Of cell motility 1 (Memo1) in mice caused kidney disease and a bone disease with diminished osteoblast and osteoclast biomarkers in serum, resembling alterations occurring in adynamic bone disease in humans with chronic kidney ... ...

    Abstract Loss of the mediator Of cell motility 1 (Memo1) in mice caused kidney disease and a bone disease with diminished osteoblast and osteoclast biomarkers in serum, resembling alterations occurring in adynamic bone disease in humans with chronic kidney disease or in Klotho-deficient mice. Here, we investigated whether Memo1 expression in osteoblasts is required for normal bone structure and FGF23 expression. We deleted Memo1 in the osteoblast-osteocyte lineage in Memo fl/fl mice using a Cre under Col1a1 promotor to obtain osteoblast-specific knockout (obKO) mice. We studied organs by micro-computed tomography, qPCR, and western blot. We challenged mice with folic acid for acute kidney injury (AKI) and analyzed organs. Memo obKO were viable without changes in gross anatomy, serum electrolytes, or circulating FGF23 concentrations compared to controls. Memo1 expression was blunted in bones of Memo obKO, whereas it remained unchanged in other organs. Micro-CT revealed no differences between genotypes in bone structure of vertebrae, femur, and tibia. During AKI, Fgf23 expression in calvaria, and renal transcriptional changes were comparable between genotypes. However, renal injury marker expression, circulating FGF23, and parathyroid hormone revealed a sex difference with more severely affected females than males of either genotype. The present data imply that Memo1 in osteoblasts is dispensable for bone structure and expression of Fgf23. Moreover, we found evidence of potential sex differences in murine folic acid nephropathy similar to other experimental models of renal injury that are important to consider when using this experimental model of renal injury.
    MeSH term(s) Animals ; Female ; Humans ; Male ; Mice ; Acute Kidney Injury/metabolism ; Bone Diseases/metabolism ; Fibroblast Growth Factors/metabolism ; Folic Acid/metabolism ; Intracellular Signaling Peptides and Proteins/metabolism ; Kidney/metabolism ; Osteoblasts/metabolism ; X-Ray Microtomography
    Chemical Substances Fibroblast Growth Factors (62031-54-3) ; Folic Acid (935E97BOY8) ; Intracellular Signaling Peptides and Proteins ; Memo1 protein, mouse
    Language English
    Publishing date 2023-03-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2724325-4
    ISSN 2051-817X ; 2051-817X
    ISSN (online) 2051-817X
    ISSN 2051-817X
    DOI 10.14814/phy2.15650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years.

    Strumann, Christoph / Ranzani, Otavio / Moor, Jeanne / Berner, Reinhard / Töpfner, Nicole / Chao, Cho-Ming / Moor, Matthias B

    The Journal of clinical investigation

    2023  Volume 133, Issue 21

    MeSH term(s) Humans ; Child ; Child, Preschool ; BNT162 Vaccine ; COVID-19 Vaccines ; COVID-19/prevention & control
    Chemical Substances BNT162 Vaccine ; COVID-19 Vaccines
    Language English
    Publishing date 2023-11-01
    Publishing country United States
    Document type Letter
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI173329
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Severe hypomagnesemia.

    Schietzel, Simeon / Moor, Matthias B / Fuster, Daniel G

    Journal of nephrology

    2021  Volume 34, Issue 6, Page(s) 2123–2126

    MeSH term(s) Humans ; Magnesium ; Magnesium Deficiency/diagnosis ; Proton Pump Inhibitors
    Chemical Substances Proton Pump Inhibitors ; Magnesium (I38ZP9992A)
    Language English
    Publishing date 2021-03-09
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1093991-x
    ISSN 1724-6059 ; 1120-3625 ; 1121-8428
    ISSN (online) 1724-6059
    ISSN 1120-3625 ; 1121-8428
    DOI 10.1007/s40620-021-01001-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Memo1 gene expression in kidney and bone is unaffected by dietary mineral load and calciotropic hormones.

    Moor, Matthias B / Bonny, Olivier

    Physiological reports

    2020  Volume 8, Issue 7, Page(s) e14410

    Abstract: Mediator of cell motility 1 (MEMO1) is a ubiquitously expressed modulator of cellular responses to growth factors including FGF23 signaling, and Memo1-deficient mice share some phenotypic traits with Fgf23- or Klotho-deficient mouse models. Here, we ... ...

    Abstract Mediator of cell motility 1 (MEMO1) is a ubiquitously expressed modulator of cellular responses to growth factors including FGF23 signaling, and Memo1-deficient mice share some phenotypic traits with Fgf23- or Klotho-deficient mouse models. Here, we tested whether Memo1 gene expression is regulated by calciotropic hormones or by changing the dietary mineral load. MLO-Y4 osteocyte-like cells were cultured and treated with 1,25(OH)
    MeSH term(s) Animals ; Bone and Bones/drug effects ; Bone and Bones/metabolism ; Calcium, Dietary/pharmacology ; Cell Line ; Cholecalciferol/administration & dosage ; Diet ; Fibroblast Growth Factor-23 ; Fibroblast Growth Factors/metabolism ; Gene Expression Regulation ; Intracellular Signaling Peptides and Proteins/biosynthesis ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Kidney/drug effects ; Kidney/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Phosphates/pharmacology ; Random Allocation
    Chemical Substances Calcium, Dietary ; Fgf23 protein, mouse ; Intracellular Signaling Peptides and Proteins ; Memo1 protein, mouse ; Phosphates ; Cholecalciferol (1C6V77QF41) ; Fibroblast Growth Factors (62031-54-3) ; Fibroblast Growth Factor-23 (7Q7P4S7RRE)
    Language English
    Publishing date 2020-04-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2724325-4
    ISSN 2051-817X ; 2051-817X
    ISSN (online) 2051-817X
    ISSN 2051-817X
    DOI 10.14814/phy2.14410
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years

    Christoph Strumann / Otavio Ranzani / Jeanne Moor / Reinhard Berner / Nicole Töpfner / Cho-Ming Chao / Matthias B. Moor

    The Journal of Clinical Investigation, Vol 133, Iss

    2023  Volume 21

    Keywords Infectious disease ; Vaccines ; Medicine ; R
    Language English
    Publishing date 2023-11-01T00:00:00Z
    Publisher American Society for Clinical Investigation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies - Authors' reply.

    Moor, Matthias B / Suter-Riniker, Franziska / Hirzel, Cedric / Maurer, Britta / Sidler, Daniel

    The Lancet. Rheumatology

    2022  Volume 4, Issue 4, Page(s) e247–e248

    Language English
    Publishing date 2022-03-24
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(22)00035-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort study

    Moor, Jeanne / Toepfner, Nicole / von Meißner, Wolfgang C G / Berner, Reinhard / Moor, Matthias B. / Kublickiene, Karolina / Strumann, Christoph / Chao, Cho-Ming

    medRxiv

    Abstract: Background Sex differences exist not only in the efficacy but also in adverse event rates of many vaccines. Here we compared the safety of BNT162b2 vaccine administered off-label in female and male children younger than 5 years in Germany. Methods This ... ...

    Abstract Background Sex differences exist not only in the efficacy but also in adverse event rates of many vaccines. Here we compared the safety of BNT162b2 vaccine administered off-label in female and male children younger than 5 years in Germany. Methods This is a retrospective cohort study, in which we performed a post-hoc analysis of a dataset collected through an authentication-based survey of individuals having registered children aged 0-<5 years for vaccination against SARS-CoV-2 in six private practices and/or two lay person-initiated vaccination campaigns. We analyzed the safety profiles of the first 3 doses of 3-10μg BNT162b2. Primary outcome was comparison in frequencies of 4 common post-vaccination symptom categories such as local, general, musculoskeletal symptoms and fever. Data were analyzed according to sex in bivariate analyses and regression models adjusting for age, weight, and dosage. Interaction between sex and BNT162b2 dosage was assessed. An active-comparator analysis was applied to compare post-vaccination symptoms after BNT162b2 versus non-SARS-CoV-2 vaccines. Results The dataset for the present analysis consisted of 7801 participants including 3842 females (49%) and 3977 males (51%) with an age of 3 years (median, interquartile: 2 years). Among individuals receiving 3μg BNT162b2, no sex differences were noted, but after a first dose of 5 or 10μg BNT162b2, local injection-site symptoms were more prevalent in girls compared to boys. In logistic regression, female sex was associated with higher odds of local symptoms, odds ratio (OR) of 1.33 (95% confidence interval [CI]: 1.15-1.55, p<0.05) and general symptoms with OR 1.21 (95% CI: 1.01-1.44, p<0.05). Following non-BNT162b2 childhood vaccinations, female sex was associated with a lower odds of post-vaccination musculoskeletal symptoms (OR: 0.29, 95% CI: 0.11-0.82, p<0.05). An active comparator analysis between BNT162b2 and non-SARS-CoV-2 vaccinations revealed that female sex positively influenced the association between BNT162b2 vaccine type and musculoskeletal symptoms. Conclusions Sex differences exist in post-vaccination symptoms after BNT162b2 administration even in young children. These are of importance for the conception of approval studies, for post-vaccination monitoring and for future vaccination strategies. (German Clinical Trials Register ID: DRKS00028759).
    Keywords covid19
    Language English
    Publishing date 2024-03-13
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2024.03.08.24303999
    Database COVID19

    Kategorien

  8. Article ; Online: Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort study

    Moor, Jeanne / Toepfner, Nicole / von Meissner, Wolfgang C. G. / Berner, Reinhard / Moor, Matthias B. / Kublickiene, Karolina / Strumann, Christoph / Chao, Cho-Ming

    medRxiv

    Abstract: Background Sex differences exist not only in the efficacy but also in adverse event rates of many vaccines. Here we compared the safety of BNT162b2 vaccine administered off-label in female and male children younger than 5 years in Germany. Methods This ... ...

    Abstract Background Sex differences exist not only in the efficacy but also in adverse event rates of many vaccines. Here we compared the safety of BNT162b2 vaccine administered off-label in female and male children younger than 5 years in Germany. Methods This is a retrospective cohort study, in which we performed a post-hoc analysis of a dataset collected through an authentication-based survey of individuals having registered children aged 0-<5 years for vaccination against SARS-CoV-2 in six private practices and/or two lay person-initiated vaccination campaigns. We analyzed the safety profiles of the first 3 doses of 3-10μg BNT162b2. Primary outcome was comparison in frequencies of 4 common post-vaccination symptom categories such as local, general, musculoskeletal symptoms and fever. Data were analyzed according to sex in bivariate analyses and regression models adjusting for age, weight, and dosage. Interaction between sex and BNT162b2 dosage was assessed. An active-comparator analysis was applied to compare post-vaccination symptoms after BNT162b2 versus non-SARS-CoV-2 vaccines. Results The dataset for the present analysis consisted of 7801 participants including 3842 females (49%) and 3977 males (51%) with an age of 3 years (median, interquartile: 2 years). Among individuals receiving 3μg BNT162b2, no sex differences were noted, but after a first dose of 5 or 10μg BNT162b2, local injection-site symptoms were more prevalent in girls compared to boys. In logistic regression, female sex was associated with higher odds of local symptoms, odds ratio (OR) of 1.33 (95% confidence interval [CI]: 1.15-1.55, p<0.05) and general symptoms with OR 1.21 (95% CI: 1.01-1.44, p<0.05). Following non-BNT162b2 childhood vaccinations, female sex was associated with a lower odds of post-vaccination musculoskeletal symptoms (OR: 0.29, 95% CI: 0.11-0.82, p<0.05). An active comparator analysis between BNT162b2 and non-SARS-CoV-2 vaccinations revealed that female sex positively influenced the association between BNT162b2 vaccine type and musculoskeletal symptoms. Conclusions Sex differences exist in post-vaccination symptoms after BNT162b2 administration even in young children. These are of importance for the conception of approval studies, for post-vaccination monitoring and for future vaccination strategies. (German Clinical Trials Register ID: DRKS00028759).
    Keywords covid19
    Language English
    Publishing date 2024-03-13
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2024.03.08.24303999
    Database COVID19

    Kategorien

  9. Article: HPV Vaccination in Immunosuppressed Patients with Established Skin Warts and Non-Melanoma Skin Cancer: A Single-Institutional Cohort Study.

    Bossart, Simon / Daneluzzi, Cloé / Moor, Matthias B / Hirzel, Cédric / Heidemeyer, Kristine / Seyed Jafari, S Morteza / Hunger, Robert E / Sidler, Daniel

    Vaccines

    2023  Volume 11, Issue 9

    Abstract: cSCC (cutaneous squamous cell carcinoma) and its precursors are a major cause of morbidity, especially in immunosuppressed patients, and are frequently associated with human papillomavirus (HPV) infections. The purpose of this study is to investigate the ...

    Abstract cSCC (cutaneous squamous cell carcinoma) and its precursors are a major cause of morbidity, especially in immunosuppressed patients, and are frequently associated with human papillomavirus (HPV) infections. The purpose of this study is to investigate the therapeutic potential of alpha-HPV vaccination for immunosuppressed patients with established cSCC and its precursors. In this retrospective study, all patients who received Gardasil-9
    Language English
    Publishing date 2023-09-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines11091490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers.

    Moor, Matthias B / Dhayat, Nasser A / Schietzel, Simeon / Grössl, Michael / Vogt, Bruno / Fuster, Daniel G

    Urolithiasis

    2022  Volume 50, Issue 3, Page(s) 333–340

    Abstract: The spectrum of diseases with overactive renin-angiotensin-aldosterone system (RAS) or elevated circulating FGF23 overlaps, but the relationship between aldosterone and FGF23 remains unclarified. Here, we report that systemic RAS activation sensitively ... ...

    Abstract The spectrum of diseases with overactive renin-angiotensin-aldosterone system (RAS) or elevated circulating FGF23 overlaps, but the relationship between aldosterone and FGF23 remains unclarified. Here, we report that systemic RAS activation sensitively assessed by urinary tetrahydroaldosterone excretion is associated with circulating C-terminal FGF23. We performed a retrospective analysis in the Bern Kidney Stone Registry, a single-center observational cohort of kidney stone formers. Urinary excretion of the main aldosterone metabolite tetrahydroaldosterone was measured by gas chromatography-mass spectrometry. Plasma FGF23 concentrations were measured using a C-terminal assay. Regression models were calculated to assess the association of plasma FGF23 with 24 h urinary tetrahydroaldosterone excretion. We included 625 participants in the analysis. Mean age was 47 ± 14 years and 71% were male. Mean estimated GFR was 94 ml/min per 1.73 m
    MeSH term(s) Adult ; Aldosterone/analogs & derivatives ; Aldosterone/urine ; Cohort Studies ; Female ; Fibroblast Growth Factor-23/blood ; Gas Chromatography-Mass Spectrometry ; Humans ; Kidney Calculi/blood ; Kidney Calculi/urine ; Male ; Middle Aged ; Multivariate Analysis ; Potassium/administration & dosage ; Potassium/urine ; Registries ; Regression Analysis ; Retrospective Studies ; Sodium/administration & dosage ; Sodium/urine
    Chemical Substances FGF23 protein, human ; tetrahydroaldosterone (13489-75-3) ; Aldosterone (4964P6T9RB) ; Fibroblast Growth Factor-23 (7Q7P4S7RRE) ; Sodium (9NEZ333N27) ; Potassium (RWP5GA015D)
    Language English
    Publishing date 2022-02-24
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2703553-0
    ISSN 2194-7236 ; 2194-7228
    ISSN (online) 2194-7236
    ISSN 2194-7228
    DOI 10.1007/s00240-022-01317-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top